Form 4 for RMD ResMed|
Accepted 2022-11-29 00:00:00 ET · period of report 2022-11-25 · accession 0001127602-22-026463 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-29 | 2022-11-25 | RMD | PENDARVIS DAVID | Chief Administrative Off | M - OptEx | $146.34 | +683 | 107.5K | +0.6% | +$100.0K |
| D | 2022-11-29 | 2022-11-28 | RMD | PENDARVIS DAVID | Chief Administrative Off | G - Gift | $0.00 | -7,300 | 100.2K | -7% | $0 |
| D | 2022-11-29 | 2022-11-25 | RMD | PENDARVIS DAVID | Chief Administrative Off | M - OptEx | $0.00 | -683 | 12.5K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-11-25 | M | A | 683 | $146.34 | 107,472 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2022-11-28 | G | D | 7,300 | $0.00 | 100,172 | D | — | — | |
| 3 | Derivative | ResMed Common Stock Options | 2022-11-25 | M | D | 683 | $0.00 | 12,540 | D | $146.34 · 2020-11-11 to 2026-11-21 | 683 ResMed Common Stock | (F2) Represents date options first became exercisable. Options vest 1/3 per year. |